NasdaqCM:FTHBiotechs
Faeth Therapeutics (FTH) Sets October PIKTOR Event, Is The Premium Already Priced In?
Faeth Therapeutics (FTH) has drawn fresh attention after scheduling a virtual key opinion leader event on October 6 focused on its lead drug PIKTOR for endometrial cancer, along with multiple healthcare conference appearances in September.
Faeth Therapeutics has seen sharp swings, with the share price down 7.9% on the day and 7.7% over the past week, yet still showing a 26.4% 1 month share price return and a very large 90 day gain. The 1 year total shareholder return of 324.9% contrasts with...